NYSEAMERICAN:PLX - Protalix Biotherapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$0.4534 0.00 (0.00 %)
(As of 02/17/2019 04:00 PM ET)
Previous Close$0.4534
Today's Range$0.4390 - $0.47
52-Week Range$0.27 - $0.83
Volume304,175 shs
Average Volume774,904 shs
Market Capitalization$67.27 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Protalix Biotherapeutics (NYSEAMERICAN:PLX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Protalix Biotherapeutics in the last 12 months. Their average twelve-month price target is $4.00, suggesting that the stock has a possible upside of 782.22%. The high price target for PLX is $4.00 and the low price target for PLX is $4.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.00$4.00$4.00$4.00
Price Target Upside: 782.22% upside875.61% upside515.38% upside716.33% upside

Protalix Biotherapeutics (NYSEAMERICAN:PLX) Consensus Price Target History

Price Target History for Protalix Biotherapeutics (NYSEAMERICAN:PLX)

Protalix Biotherapeutics (NYSEAMERICAN:PLX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
12/13/2018HC WainwrightSet Price TargetBuy$4.00View Rating Details
5/23/2017Rodman & RenshawReiterated RatingBuy$5.00View Rating Details
(Data available from 2/17/2017 forward)
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel